Compare HCA Health Inc (HCA) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance

HCA Healthcare trades at $449.47, up 2.35% with bullish technical indicators and strong fundamental performance. The stock shows consistent earnings beats with Q2 2026 EPS of $7.59 exceeding expectations, while revenue growth continues from $75.6B in 2025 to projected $78.0B in 2026. Analyst consensus remains strongly positive with 63% buy ratings and $461.12 price target, though legal investigations present headwinds.

The outlook remains favorable with solid patient demand and operational efficiency driving growth, though investors should monitor ongoing legal investigations and debt levels. Valuation appears reasonable with P/E of 14.92 and EV/EBITDA of 9.26, while technical support at $440 provides near-term stability.

ZIM trades at $30.12, up 0.43% on the day and near its 52-week high of $30.96, reflecting strong momentum. The technical outlook is bullish, supported by moving averages, while fundamentals show mixed signals with a low P/S of 0.57 and EV/EBITDA of 3.81, but declining profitability margins. Recent Q2 2026 earnings beat expectations with EPS of $0.53 versus a forecasted loss, though revenue and net income are trending lower year-over-year. Key news includes a pending $35 per share acquisition offer from Hapag-Lloyd, subject to Israeli government approval, creating significant event-driven uncertainty.

The investment case hinges on the acquisition outcome; approval could deliver immediate upside to $35, while rejection may pressure shares despite operational improvements. Risks include earnings volatility, geopolitical factors affecting the deal, and exposure to cyclical shipping rates. Analyst sentiment is cautious with no buy ratings, reflecting the binary nature of the takeover situation. The stock offers value on a sales basis but requires careful risk management due to the high-stakes merger dynamics.